BC Cancer Research Seminar Series and Trainee Lunch and Learn
Supported by the BC Cancer Foundation, the BC Cancer Research Seminar Series hosts prominent researchers in the cancer field for monthly seminars on Mondays at 12pm. Trainees are able to register for a Lunch and Learn session with the speaker, held from 1-2pm.
Next Speaker
Past Speakers
2025
APRIL 14TH: Dr. Yvonne Bombard, pHd
Professor and Canada Research Chair in Genomics Health Services, University of Toronto
Opportunistic Genomic screening in cancer patients: outcomes, costs & scalability
MARCH 21st: Dr. Helder Nakaya, pHd
Associate professor at the University of São Paulo, Brazil
Next-Gen Healthcare with AI-Powered Omics (KEYNOTE TALK AT BIG RESEARCH DAY 2025)
MARCH 17th: Dr. David Papadopoli, pHd
Postdoctoral Fellow, Lady Davis Institute of the Jewish Hospital, McGill University
Unravelling pillars of metabolic plasticity in cancer
MARCH 17th: Dr. Matthew Vander Heiden, pHd
Director of the Koch Institute for Integrative Cancer Research, Lester Wolfe Chair in Molecular Biology, and MIT Biology Professor
How Altered Metabolism Influences Cancer Progression
MARCH 11th: Dr. Krysta Coyle , pHd
Postdoctoral Fellow, Simon Fraser University
Splicing things up in B cell neoplasms: A large-scale multiomic meta-analysis
MARCH 10th: Dr. Graham Dellaire, pHd
Distinguished Professor, Dept. of Pathology, Dalhousie University
Using Evolutionary Molecular Biology to Uncover a Conserved Function of the Tumour Suppressor PRP4K in Autophagy
february 3rd: DR. davide ruggero, pHd
Professor of Urology at the University of California, San Francisco
Nutrition, Cancer and RNA Structure: A Journey into New Modes of Gene Regulation
january 13th: DR. christopher oakes, pHd
Associate Professor in the Departments of Internal Medicine and Biomedical Informatics at the Ohio State University
Deciphering the Epigenome to Improve Therapeutic Precision in Leukemia
2024
december 9th: DR. rosana pelayo, pHd
Head, Health Education and Research. Full Professor in Oncoimmunology and Cytomics. Mexican Institute for Social Security, Mexico
ADDRESSING CHILDHOOD LEUKEMIA IN VULNERABLE POPULATIONS IN MEXICO FROM A COMPLEXITY PERSPECTIVE
november 4th: DR. Stephanie zhi-juan xie, pHd
Affiliate Scientist at Princess Margaret Cancer Centre, Toronto
Stressing Human Hematopoietic Stem Cells to Understand Aging and Pre-leukemia
October 21st: Dr. David Knapp, phd
Principle Investigator, Cellular Engineering Research Unit, IRIC, Department of Pathology and Cell Biology, Faculty of Medicine, University of Montreal
Dissecting Cellular Crosstalk and Regulatory Networks via Precision Engineering and Spatial Measurements
October 7th: Dr. joseph lehar, phd
Advisor to various Biotechs, Incubators, & Funds
Precision Medicine at Scale: Towards Finding the Right Treatment for Every Patient
september 16th: Dr. Kanaga Sabapathy, phd
Professor & Chair, School of Biological Sciences, Nanyang Technological University
P53 THERAPY FOR SPORADIC AND FAMILIAL LI-FRAUMENI SYNDROME CANCERS
July 15th: Dr. Mamiko Sakata-Yanagimoto, md, phd
Professor in the Department of Hematology, Institute of Medicine, and in the Division of Advanced Hemato-Oncology, Transborder Medical Research Center at the University of Tsukuba
Immune Cells with Somatic Mutations Function as a niche for cancer cells
June 24th: Dr. frank wuest, phd
Professor and Chair of the Department of Oncology at the University of Alberta
Imaging Biomarkers in Oncology: The Role of Radionuclides and Radiopharmaceuticals in the Era of Precision Oncology
may 6th: Dr. gina m. denicola, phd
Leader of the Metabolism Program at Moffitt Cancer Center
NRF2 and Cysteine Metabolism in Cancer
april 15th: Dr. daniela quail, phd
Assistant Professor at the Rosalind and Morris Goodman Cancer Institute and the Department of Physiology at McGill University
Fuelling Cancer Progression Through the Myeloid Compartment
march 4th: Dr. daniel schramek, phd
Senior Investigator at the Lunenfeld-Tanenbaum Research Institute at Toronto’s Mount Sinai Hospital and Associate Professor at the Department of Molecular Genetics, Temerty Faculty of Medicine, University of Toronto. Canadian Research Chair in Functional Cancer Genomics
In Vivo Veritas - Using CRISPR Technologies in Mice to Unravel Novel Cancer Driver Alterations and Novel Drug Targets
february 5th: Dr. nicolette fonseca, phd
Postdoctoral Research Fellow at the Vancouver Prostate Centre and the Department of Urologic Sciences, University of British Columbia
Leveraging Circulating Tumor DNA for Genomic and Immune Biomarker Discovery in Prostate Cancer
january 8th: Dr. sarah crome, phd
Senior Scientist at the Toronto General Hospital Research Institute within University Health Network (UHN), and Assistant Professor in the Department of Immunology at the University of Toronto